Holen Sie sich die Stockscreener-App
2.59
4.78%
-0.13
Handel nachbörslich:
2.53
-0.06
-2.32%
Schlusskurs vom Vortag:
$2.72
Offen:
$2.73
24-Stunden-Volumen:
82,689
Relative Volume:
0.26
Marktkapitalisierung:
$24.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.47%
1M Leistung:
+71.52%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.42
$2.9301
1-Wochen-Bereich:
$2.23
$3.40
52-Wochen-Spanne:
$1.42
$5.50
Gelteq Ltd Stock (GELS) Company Profile
Vergleichen Sie GELS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
2.59 | 24.44M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Gelteq Ltd Aktie (GELS) Neueste Nachrichten
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl
Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal
Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn
Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World
Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World
Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan
Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com
Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online
Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia
Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India
Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times
GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan
Gelteq Closes $5.2M IPO - Investing.com
Argent Biopharma Lists New Shares on ASX - MSN
Biotech company Gelteq prices IPO at $4 per share - MSN
Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN
Maas Group Reports Record Results and Growth Strategy - MSN
Qualitas Limited Releases 2024 Governance Statement - MSN
Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha
WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN
Novatti Group Announces Hybrid Annual General Meeting - MSN
Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times
RooLife Group Announces AGM with Key Resolutions - MSN
Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN
Strike Resources Limited Announces Upcoming AGM Details - MSN
IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha
Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project
Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World
SkyView Investment Advisors LLC Boosts Stock Holdings in General Electric (NYSE:GE) - Defense World
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga
Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies - GlobalData
AST SpaceMobile registers shares in Antares reorg - MSN
AN2 Therapeutics (NASDAQ:ANTX) Stock Quotes, Forecast and News Summary - Benzinga
Cingulate (NASDAQ:CING) Stock Quotes, Forecast and News Summary - Benzinga
Reviva Pharmaceuticals (NASDAQ:RVPH) Stock Quotes, Forecast and News Summary - Benzinga
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Quotes, Forecast and News Summary - Benzinga
Marinus Pharma (NASDAQ:MRNS) Stock Quotes, Forecast and News Summary - Benzinga
IGC Pharma (AMEX:IGC) Stock Quotes, Forecast and News Summary - Benzinga
Free Stock Market Newsletter | MarketBeat Daily Ratings - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
InvestorsHubNYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News - InvestorsHub
Finanzdaten der Gelteq Ltd-Aktie (GELS)
Es liegen keine Finanzdaten für Gelteq Ltd (GELS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):